APO Research
Talk to an analyst

APO RESEARCH · REPORT

Platinum-based Anticancer Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Platinum-based Anticancer Drugs Industry Research Report 2026

20 December 2025132 pages

Choose your research edition.

Industry ResearchPlatinum-based Anticancer Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Platinum-based Anticancer Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Platinum-based Anticancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Platinum-based Anticancer Drugs Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Platinum-based Anticancer Drugs Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Platinum-based Anticancer Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Platinum-based Anticancer Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Platinum-based Anticancer Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Platinum-based Anticancer Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Platinum-based Anticancer Drugs include Teva, Sun Pharmaceutical, Qilu Pharmaceutical, Nanjing Pharmaceutical Factory, Mylan, Luoxin, Jiangsu Aosaikang Pharmaceutical, Jiangsu Hengrui Medicine and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Platinum-based Anticancer Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Platinum-based Anticancer Drugs Market by Company

Teva

Sun Pharmaceutical

Qilu Pharmaceutical

Nanjing Pharmaceutical Factory

Mylan

Luoxin

Jiangsu Aosaikang Pharmaceutical

Jiangsu Hengrui Medicine

Fresenius Kabi

Yakult honsha

Taj Pharmaceuticals

Sanofi-Aventis

Lingnan Pharmacy

Hospira(Pfizer)

Hisun Pharmaceutical

Hansoh Pharma

Dr Reddy's laboratories

Platinum-based Anticancer Drugs Segment by Type

Oxaliplatin

Carboplatin

Nedaplatin

Cisplatin

Others

Platinum-based Anticancer Drugs Segment by Application

Esophageal Cancer

Breast Cancer

Osteosarcoma

Testicular Cancer

NSCLC

Other

Platinum-based Anticancer Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum-based Anticancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Platinum-based Anticancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum-based Anticancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Platinum-based Anticancer Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Platinum-based Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Platinum-based Anticancer Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Platinum-based Anticancer Drugs Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Platinum-based Anticancer Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Platinum-based Anticancer Drugs Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Platinum-based Anticancer Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Platinum-based Anticancer Drugs, Product Type & Application Table 14. Global Platinum-based Anticancer Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Platinum-based Anticancer Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Company Information Table 19. Teva Business Overview Table 20. Teva Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. Teva Platinum-based Anticancer Drugs Product Portfolio Table 22. Teva Recent Developments Table 23. Sun Pharmaceutical Company Information Table 24. Sun Pharmaceutical Business Overview Table 25. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 27. Sun Pharmaceutical Recent Developments Table 28. Qilu Pharmaceutical Company Information Table 29. Qilu Pharmaceutical Business Overview Table 30. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 32. Qilu Pharmaceutical Recent Developments Table 33. Nanjing Pharmaceutical Factory Company Information Table 34. Nanjing Pharmaceutical Factory Business Overview Table 35. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Portfolio Table 37. Nanjing Pharmaceutical Factory Recent Developments Table 38. Mylan Company Information Table 39. Mylan Business Overview Table 40. Mylan Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. Mylan Platinum-based Anticancer Drugs Product Portfolio Table 42. Mylan Recent Developments Table 43. Luoxin Company Information Table 44. Luoxin Business Overview Table 45. Luoxin Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Luoxin Platinum-based Anticancer Drugs Product Portfolio Table 47. Luoxin Recent Developments Table 48. Jiangsu Aosaikang Pharmaceutical Company Information Table 49. Jiangsu Aosaikang Pharmaceutical Business Overview Table 50. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 52. Jiangsu Aosaikang Pharmaceutical Recent Developments Table 53. Jiangsu Hengrui Medicine Company Information Table 54. Jiangsu Hengrui Medicine Business Overview Table 55. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Portfolio Table 57. Jiangsu Hengrui Medicine Recent Developments Table 58. Fresenius Kabi Company Information Table 59. Fresenius Kabi Business Overview Table 60. Fresenius Kabi Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Fresenius Kabi Platinum-based Anticancer Drugs Product Portfolio Table 62. Fresenius Kabi Recent Developments Table 63. Yakult honsha Company Information Table 64. Yakult honsha Business Overview Table 65. Yakult honsha Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Yakult honsha Platinum-based Anticancer Drugs Product Portfolio Table 67. Yakult honsha Recent Developments Table 68. Taj Pharmaceuticals Company Information Table 69. Taj Pharmaceuticals Business Overview Table 70. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Portfolio Table 72. Taj Pharmaceuticals Recent Developments Table 73. Sanofi-Aventis Company Information Table 74. Sanofi-Aventis Business Overview Table 75. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Sanofi-Aventis Platinum-based Anticancer Drugs Product Portfolio Table 77. Sanofi-Aventis Recent Developments Table 78. Lingnan Pharmacy Company Information Table 79. Lingnan Pharmacy Business Overview Table 80. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Portfolio Table 82. Lingnan Pharmacy Recent Developments Table 83. Hospira(Pfizer) Company Information Table 84. Hospira(Pfizer) Business Overview Table 85. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Portfolio Table 87. Hospira(Pfizer) Recent Developments Table 88. Hisun Pharmaceutical Company Information Table 89. Hisun Pharmaceutical Business Overview Table 90. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 92. Hisun Pharmaceutical Recent Developments Table 93. Hansoh Pharma Company Information Table 94. Hansoh Pharma Business Overview Table 95. Hansoh Pharma Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Hansoh Pharma Platinum-based Anticancer Drugs Product Portfolio Table 97. Hansoh Pharma Recent Developments Table 98. Dr Reddy's laboratories Company Information Table 99. Dr Reddy's laboratories Business Overview Table 100. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Portfolio Table 102. Dr Reddy's laboratories Recent Developments Table 103. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Platinum-based Anticancer Drugs Sales by Region (2021-2026) & (Tons) Table 105. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2021-2026) Table 106. Global Platinum-based Anticancer Drugs Sales by Region (2027-2032) & (Tons) Table 107. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2027-2032) Table 108. Global Platinum-based Anticancer Drugs Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2021-2026) Table 110. Global Platinum-based Anticancer Drugs Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2027-2032) Table 112. North America Platinum-based Anticancer Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 114. North America Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 115. North America Platinum-based Anticancer Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Platinum-based Anticancer Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Platinum-based Anticancer Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 119. Europe Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 120. Europe Platinum-based Anticancer Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Platinum-based Anticancer Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Platinum-based Anticancer Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 124. Asia Pacific Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 125. Asia Pacific Platinum-based Anticancer Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Platinum-based Anticancer Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Platinum-based Anticancer Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 129. South America Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 130. South America Platinum-based Anticancer Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Platinum-based Anticancer Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 134. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 135. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Platinum-based Anticancer Drugs Sales by Type (2021-2026) & (Tons) Table 138. Global Platinum-based Anticancer Drugs Sales by Type (2027-2032) & (Tons) Table 139. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2021-2026) Table 140. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2027-2032) Table 141. Global Platinum-based Anticancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Platinum-based Anticancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2021-2026) Table 144. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2027-2032) Table 145. Global Platinum-based Anticancer Drugs Price by Type (2021-2026) & (US$/Ton) Table 146. Global Platinum-based Anticancer Drugs Price by Type (2027-2032) & (US$/Ton) Table 147. Global Platinum-based Anticancer Drugs Sales by Application (2021-2026) & (Tons) Table 148. Global Platinum-based Anticancer Drugs Sales by Application (2027-2032) & (Tons) Table 149. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2021-2026) Table 150. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2027-2032) Table 151. Global Platinum-based Anticancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Platinum-based Anticancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2021-2026) Table 154. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2027-2032) Table 155. Global Platinum-based Anticancer Drugs Price by Application (2021-2026) & (US$/Ton) Table 156. Global Platinum-based Anticancer Drugs Price by Application (2027-2032) & (US$/Ton) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Platinum-based Anticancer Drugs Distributors List Table 160. Platinum-based Anticancer Drugs Customers List Table 161. Platinum-based Anticancer Drugs Industry Trends Table 162. Platinum-based Anticancer Drugs Industry Drivers Table 163. Platinum-based Anticancer Drugs Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Platinum-based Anticancer Drugs Product Image Figure 5. Global Platinum-based Anticancer Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Platinum-based Anticancer Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Platinum-based Anticancer Drugs Sales (2021-2032) & (Tons) Figure 8. Global Platinum-based Anticancer Drugs Average Price (US$/Ton) & (2021-2032) Figure 9. Oxaliplatin Product Image Figure 10. Carboplatin Product Image Figure 11. Nedaplatin Product Image Figure 12. Cisplatin Product Image Figure 13. Others Product Image Figure 14. Esophageal Cancer Product Image Figure 15. Breast Cancer Product Image Figure 16. Osteosarcoma Product Image Figure 17. Testicular Cancer Product Image Figure 18. NSCLC Product Image Figure 19. Other Product Image Figure 20. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Platinum-based Anticancer Drugs Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Platinum-based Anticancer Drugs Sales by Region in 2025 Figure 26. Global Platinum-based Anticancer Drugs Revenue by Region in 2025 Figure 27. North America Platinum-based Anticancer Drugs Market Size by Country in 2025 Figure 28. North America Platinum-based Anticancer Drugs Sales Market Share by Country (2021-2032) Figure 29. North America Platinum-based Anticancer Drugs Revenue Market Share by Country (2021-2032) Figure 30. United States Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Platinum-based Anticancer Drugs Market Size by Country in 2025 Figure 33. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2021-2032) Figure 34. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2021-2032) Figure 35. Germany Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Platinum-based Anticancer Drugs Market Size by Country in 2025 Figure 41. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Country (2021-2032) Figure 43. China Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. China Taiwan Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Platinum-based Anticancer Drugs Market Size by Country in 2025 Figure 52. South America Platinum-based Anticancer Drugs Sales Market Share by Country (2021-2032) Figure 53. South America Platinum-based Anticancer Drugs Revenue Market Share by Country (2021-2032) Figure 54. Mexico Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Brazil Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Platinum-based Anticancer Drugs Market Size by Country in 2025 Figure 58. Middle East and Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2021-2032) Figure 60. Turkey Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. UAE Platinum-based Anticancer Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2021-2032) Figure 64. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2021-2032) Figure 65. Global Platinum-based Anticancer Drugs Price (US$/Ton) by Type (2021-2032) Figure 66. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2021-2032) Figure 67. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2021-2032) Figure 68. Global Platinum-based Anticancer Drugs Price (US$/Ton) by Application (2021-2032) Figure 69. Platinum-based Anticancer Drugs Value Chain Figure 70. Platinum-based Anticancer Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Platinum-based Anticancer Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Oxaliplatin
  • Carboplatin
  • Nedaplatin
  • Cisplatin
  • Others
Applications
  • Esophageal Cancer
  • Breast Cancer
  • Osteosarcoma
  • Testicular Cancer
  • NSCLC
  • Other
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Qilu Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Mylan
  • Luoxin
  • Jiangsu Aosaikang Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Fresenius Kabi
  • Yakult honsha
  • Taj Pharmaceuticals
  • Sanofi-Aventis
  • Lingnan Pharmacy
  • Hospira(Pfizer)
  • Hisun Pharmaceutical
  • Hansoh Pharma
  • Dr Reddy's laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Platinum-based Anticancer Drugs Market Size (2021-2032)
  4. 2.2.2 Global Platinum-based Anticancer Drugs Sales (2021-2032)
  5. 2.2.3 Global Platinum-based Anticancer Drugs Market Average Price (2021-2032)
  6. 2.3 Platinum-based Anticancer Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Oxaliplatin
  9. 2.3.3 Carboplatin
  10. 2.3.4 Nedaplatin
  11. 2.3.5 Cisplatin
  12. 2.3.6 Others
  13. 2.4 Platinum-based Anticancer Drugs by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Esophageal Cancer
  16. 2.4.3 Breast Cancer
  17. 2.4.4 Osteosarcoma
  18. 2.4.5 Testicular Cancer
  19. 2.4.6 NSCLC
  20. 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Platinum-based Anticancer Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Platinum-based Anticancer Drugs Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Platinum-based Anticancer Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Platinum-based Anticancer Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Platinum-based Anticancer Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Platinum-based Anticancer Drugs, Established Date
  9. 3.9 Global Platinum-based Anticancer Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva
  2. 4.1.1 Teva Company Information
  3. 4.1.2 Teva Business Overview
  4. 4.1.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Platinum-based Anticancer Drugs Product Portfolio
  6. 4.1.5 Teva Recent Developments
  7. 4.2 Sun Pharmaceutical
  8. 4.2.1 Sun Pharmaceutical Company Information
  9. 4.2.2 Sun Pharmaceutical Business Overview
  10. 4.2.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  12. 4.2.5 Sun Pharmaceutical Recent Developments
  13. 4.3 Qilu Pharmaceutical
  14. 4.3.1 Qilu Pharmaceutical Company Information
  15. 4.3.2 Qilu Pharmaceutical Business Overview
  16. 4.3.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  18. 4.3.5 Qilu Pharmaceutical Recent Developments
  19. 4.4 Nanjing Pharmaceutical Factory
  20. 4.4.1 Nanjing Pharmaceutical Factory Company Information
  21. 4.4.2 Nanjing Pharmaceutical Factory Business Overview
  22. 4.4.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Portfolio
  24. 4.4.5 Nanjing Pharmaceutical Factory Recent Developments
  25. 4.5 Mylan
  26. 4.5.1 Mylan Company Information
  27. 4.5.2 Mylan Business Overview
  28. 4.5.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Mylan Platinum-based Anticancer Drugs Product Portfolio
  30. 4.5.5 Mylan Recent Developments
  31. 4.6 Luoxin
  32. 4.6.1 Luoxin Company Information
  33. 4.6.2 Luoxin Business Overview
  34. 4.6.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Luoxin Platinum-based Anticancer Drugs Product Portfolio
  36. 4.6.5 Luoxin Recent Developments
  37. 4.7 Jiangsu Aosaikang Pharmaceutical
  38. 4.7.1 Jiangsu Aosaikang Pharmaceutical Company Information
  39. 4.7.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  40. 4.7.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  42. 4.7.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  43. 4.8 Jiangsu Hengrui Medicine
  44. 4.8.1 Jiangsu Hengrui Medicine Company Information
  45. 4.8.2 Jiangsu Hengrui Medicine Business Overview
  46. 4.8.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Portfolio
  48. 4.8.5 Jiangsu Hengrui Medicine Recent Developments
  49. 4.9 Fresenius Kabi
  50. 4.9.1 Fresenius Kabi Company Information
  51. 4.9.2 Fresenius Kabi Business Overview
  52. 4.9.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Fresenius Kabi Platinum-based Anticancer Drugs Product Portfolio
  54. 4.9.5 Fresenius Kabi Recent Developments
  55. 4.10 Yakult honsha
  56. 4.10.1 Yakult honsha Company Information
  57. 4.10.2 Yakult honsha Business Overview
  58. 4.10.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Yakult honsha Platinum-based Anticancer Drugs Product Portfolio
  60. 4.10.5 Yakult honsha Recent Developments
  61. 4.11 Taj Pharmaceuticals
  62. 4.11.1 Taj Pharmaceuticals Company Information
  63. 4.11.2 Taj Pharmaceuticals Business Overview
  64. 4.11.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Portfolio
  66. 4.11.5 Taj Pharmaceuticals Recent Developments
  67. 4.12 Sanofi-Aventis
  68. 4.12.1 Sanofi-Aventis Company Information
  69. 4.12.2 Sanofi-Aventis Business Overview
  70. 4.12.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sanofi-Aventis Platinum-based Anticancer Drugs Product Portfolio
  72. 4.12.5 Sanofi-Aventis Recent Developments
  73. 4.13 Lingnan Pharmacy
  74. 4.13.1 Lingnan Pharmacy Company Information
  75. 4.13.2 Lingnan Pharmacy Business Overview
  76. 4.13.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Portfolio
  78. 4.13.5 Lingnan Pharmacy Recent Developments
  79. 4.14 Hospira(Pfizer)
  80. 4.14.1 Hospira(Pfizer) Company Information
  81. 4.14.2 Hospira(Pfizer) Business Overview
  82. 4.14.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Portfolio
  84. 4.14.5 Hospira(Pfizer) Recent Developments
  85. 4.15 Hisun Pharmaceutical
  86. 4.15.1 Hisun Pharmaceutical Company Information
  87. 4.15.2 Hisun Pharmaceutical Business Overview
  88. 4.15.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  90. 4.15.5 Hisun Pharmaceutical Recent Developments
  91. 4.16 Hansoh Pharma
  92. 4.16.1 Hansoh Pharma Company Information
  93. 4.16.2 Hansoh Pharma Business Overview
  94. 4.16.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hansoh Pharma Platinum-based Anticancer Drugs Product Portfolio
  96. 4.16.5 Hansoh Pharma Recent Developments
  97. 4.17 Dr Reddy's laboratories
  98. 4.17.1 Dr Reddy's laboratories Company Information
  99. 4.17.2 Dr Reddy's laboratories Business Overview
  100. 4.17.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Portfolio
  102. 4.17.5 Dr Reddy's laboratories Recent Developments
5 Global Platinum-based Anticancer Drugs Market Scenario by Region
  1. 5.1 Global Platinum-based Anticancer Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Platinum-based Anticancer Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Platinum-based Anticancer Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Platinum-based Anticancer Drugs Sales by Region: 2027-2032
  5. 5.3 Global Platinum-based Anticancer Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Platinum-based Anticancer Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Platinum-based Anticancer Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Platinum-based Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Platinum-based Anticancer Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Platinum-based Anticancer Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
  15. 5.5.1 Europe Platinum-based Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Platinum-based Anticancer Drugs Sales by Country (2021-2032)
  17. 5.5.3 Europe Platinum-based Anticancer Drugs Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Platinum-based Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Platinum-based Anticancer Drugs Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Platinum-based Anticancer Drugs Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Platinum-based Anticancer Drugs Market Facts & Figures by Country
  35. 5.7.1 South America Platinum-based Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Platinum-based Anticancer Drugs Sales by Country (2021-2032)
  37. 5.7.3 South America Platinum-based Anticancer Drugs Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Platinum-based Anticancer Drugs Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Platinum-based Anticancer Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Platinum-based Anticancer Drugs Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Platinum-based Anticancer Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Platinum-based Anticancer Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Platinum-based Anticancer Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Platinum-based Anticancer Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Platinum-based Anticancer Drugs Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Platinum-based Anticancer Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Platinum-based Anticancer Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Platinum-based Anticancer Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Platinum-based Anticancer Drugs Value Chain Analysis
  2. 8.1.1 Platinum-based Anticancer Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Platinum-based Anticancer Drugs Production Mode & Process
  5. 8.2 Platinum-based Anticancer Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Platinum-based Anticancer Drugs Distributors
  8. 8.2.3 Platinum-based Anticancer Drugs Customers
9 Global Platinum-based Anticancer Drugs Analyzing Market Dynamics
  1. 9.1 Platinum-based Anticancer Drugs Industry Trends
  2. 9.2 Platinum-based Anticancer Drugs Industry Drivers
  3. 9.3 Platinum-based Anticancer Drugs Industry Opportunities and Challenges
  4. 9.4 Platinum-based Anticancer Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst